Amundi MSCI Europe ESG Leaders UCITS ETF Acc (GBP) | ESGLRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 6.2 | 16.6 | -6.2 | 13.8 | 2.3 | |
+/-Cat | 1.9 | 1.3 | 2.1 | 2.3 | 0.1 | |
+/-B’mrk | 3.7 | -1.1 | -1.7 | 0.6 | 0.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 31/03/2024 | GBX 2832.75 | |
Day Change | 0.00% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1940199711 | |
Fund Size (Mil) 27/03/2024 | EUR 1138.61 | |
Share Class Size (Mil) 27/03/2024 | EUR 970.90 | |
Ongoing Charge 10/02/2023 | 0.20% | |
*
This rating and report were issued for a different share class of this fund. The performance and fee structure of this class may vary from that referenced. |
Morningstar Research |
Investment Objective: Amundi MSCI Europe ESG Leaders UCITS ETF Acc (GBP) | ESGL |
The investment objective of the fund is to track both the upward and the downward evolution of the MSCI Europe ESG Leaders Net Total Return Index (the "Index") denominated in Euros in order to offer an exposure to the performance of large and mid cap stocks, across developed European countries, issued by companies having a high Environmental, Social and Governance (ESG) ratings – while minimizing the volatility of the difference between the return of the Sub-Fund and the return of the Index (“Tracking Error”). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Salah Benaissa 12/02/2019 | ||
Raphaël Dieterlen 12/02/2019 | ||
Inception Date 12/02/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe ESG Leaders NR LCL | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi MSCI Europe ESG Leaders UCITS ETF Acc (GBP) | ESGL | 26/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 7.72 |
ASML Holding NV | Technology | 7.21 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 4.51 |
AstraZeneca PLC | Healthcare | 3.75 |
Novartis AG Registered Shares | Healthcare | 3.59 |
Increase Decrease New since last portfolio | ||
Amundi MSCI Europe ESG Leaders UCITS ETF Acc (GBP) | ESGL |